ASRT vs CAG · rev $125.0M vs P/E 31, rev $11.61B
Assertio Therapeutics Inc (ASRT) versus ConAgra Foods Inc (CAG) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
ConAgra Foods Inc (CAG) is a packaged foods company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported CAG revenue for 2025-05-25 was $11.61B. Net income was $1.15B. Revenue was down 3.6% from 2024-05-26 to 2025-05-25. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
ASRT currently screens at market cap $151.5M. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
Not investment advice. Open the ASRT and CAG stock pages for the full models.
Not investment advice.